Innovative global solutions through science, engineering, and technology.
Publicly-traded on the OTCQB under the symbol “DFCO”, Dalrada and its subsidiaries are positioned for stable long-term growth through intelligent market research, sound business acumen, and established operational infrastructure. The team is dedicated to scaling and accelerating business growth through exceptional financial planning, risk and business analysis, advanced technology platforms, branding, sales and marketing, human resources, legal, accounting, and administrative support.
DALRADA
Precision
DALRADA
DALRADA
Health Products
DALRADA
Precision
Digital transformation transcends traditional business functions of marketing, sales, and finance with technology, data, and workflow processes that enable organizations of all sizes to meet the challenge of new online market requirements.
Dalrada Corporation (OTCQB: DFCO, “Dalrada”) is pleased to announce to its shareholders and the public that Dr. David Bacon, was appointed to Dalrada’s Board of Directors.
GAAD 2021 Marks Seven Consecutive Years of Prakat’s Involvement and Commitment to Accessibility and Enhancing the Digital Experience for Users with Visual, Auditory, Motor, or Other Disabilities.
Dalrada Corporation (OTCQB: DFCO, “Dalrada”) reported its financial results for the third quarter of the fiscal year 2021 (ended March 31, 2021). With revenues of $1,588,329, this represents a 352% increase compared to the same period in 2020 ($351,324).
Dalrada Corporation is pleased to announce to its shareholders and the public that Mr. Kyle McCollum, CPA, has accepted the role of Chief Financial Officer.
Empower Genomics provides a custom labeled suite of tests including pharmacogenomics (PGx) and testing analysis for alternative therapies such as nutraceuticals, nutrition&diet, and exercise&fitness.
Digital transformation transcends traditional business functions of marketing, sales, and finance with technology, data, and workflow processes that enable organizations of all sizes to meet the challenge of new online market requirements.
Dalrada Corporation (OTCQB: DFCO, “Dalrada”) is pleased to announce to its shareholders and the public that Dr. David Bacon, was appointed to Dalrada’s Board of Directors.
GAAD 2021 Marks Seven Consecutive Years of Prakat’s Involvement and Commitment to Accessibility and Enhancing the Digital Experience for Users with Visual, Auditory, Motor, or Other Disabilities.
Dalrada Corporation (OTCQB: DFCO, “Dalrada”) reported its financial results for the third quarter of the fiscal year 2021 (ended March 31, 2021). With revenues of $1,588,329, this represents a 352% increase compared to the same period in 2020 ($351,324).
Innovative global solutions through science, engineering, and technology.
DALRADA
Precision
DALRADA
DALRADA
Health Products
Digital transformation transcends traditional business functions of marketing, sales, and finance with technology, data, and workflow processes that enable organizations of all sizes to meet the challenge of new online market requirements.
Dalrada Corporation (OTCQB: DFCO, “Dalrada”) is pleased to announce to its shareholders and the public that Dr. David Bacon, was appointed to Dalrada’s Board of Directors.
GAAD 2021 Marks Seven Consecutive Years of Prakat’s Involvement and Commitment to Accessibility and Enhancing the Digital Experience for Users with Visual, Auditory, Motor, or Other Disabilities.
Dalrada Corporation (OTCQB: DFCO, “Dalrada”) reported its financial results for the third quarter of the fiscal year 2021 (ended March 31, 2021). With revenues of $1,588,329, this represents a 352% increase compared to the same period in 2020 ($351,324).
Dalrada Corporation is pleased to announce to its shareholders and the public that Mr. Kyle McCollum, CPA, has accepted the role of Chief Financial Officer.
Empower Genomics provides a custom labeled suite of tests including pharmacogenomics (PGx) and testing analysis for alternative therapies such as nutraceuticals, nutrition&diet, and exercise&fitness.
